Afia B Ali is a professor of neuroscience at the UCL School of Pharmacy. She obtained a first-class honors degree in physiology at the University of Westminster in 1995 and a Ph.D. in neuroscience from University College London in 1998. Following her Ph.D., she was awarded the prestigious Wellcome International Prize Travelling Fellowship to work in Paris at the Ecole Superieure de Physique et Chimie Industrielles. In 2000, she joined the University Laboratory of Physiology at the University of Oxford as an independent research fellow funded by the Wellcome Trust and Novartis Pharmaceuticals (Basel). In 2005, she moved to the Department of Pharmacology at The School of Pharmacy, University of London as an independent fellow. In 2006 she was awarded a prestigious New Investigators Award from the Medical Research Council to work on synaptic communication between GABAergic interneurons in the hippocampus. In 2009, she was appointed a lectureship at the UCL School of Pharmacy, promoted to associate professor in 2013, and full professor of neuroscience in 2023. Her research portfolio covers multi-disciplinary projects spanning neurological disorders from epilepsy to Alzheimer’s disease and she is best known for her contribution to our understanding of mechanisms of synaptic communication in health and in Alzheimer’s disease, which plays a pivotal role in bringing new potential drugs towards pre-clinical investigations.
Afia B Ali is a professor of neuroscience at the UCL School of Pharmacy. She obtained a first-class honors degree in physiology at the University of Westminster in 1995 and a Ph.D. in neuroscience from University College London in 1998. Following her Ph.D., she was awarded the prestigious Wellcome International Prize Travelling Fellowship to work in Paris at the Ecole Superieure de Physique et Chimie Industrielles. In 2000, she joined the University Laboratory of Physiology at the University of Oxford as an independent research fellow funded by the Wellcome Trust and Novartis Pharmaceuticals (Basel). In 2005, she moved to the Department of Pharmacology at The School of Pharmacy, University of London as an independent fellow. In 2006 she was awarded a prestigious New Investigators Award from the Medical Research Council to work on synaptic communication between GABAergic interneurons in the hippocampus. In 2009, she was appointed a lectureship at the UCL School of Pharmacy, promoted to associate professor in 2013, and full professor of neuroscience in 2023. Her research portfolio covers multi-disciplinary projects spanning neurological disorders from epilepsy to Alzheimer’s disease and she is best known for her contribution to our understanding of mechanisms of synaptic communication in health and in Alzheimer’s disease, which plays a pivotal role in bringing new potential drugs towards pre-clinical investigations.